Sponsor:
Johns Hopkins University
Code:
NCT03803423
Conditions
End Stage Renal Disease
End Stage Liver Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
The Donor App
Brief summary:
Conditions
End Stage Renal Disease
End Stage Liver Disease
Study ID
NCT03803423
Start date
Nov 27, 2017
Status verified date
Nov, 2025
Completion date
Nov 27, 2026
Anticipated
Primary completion date
Nov 27, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
1000 participants
Anticipated
Intervention Model
Single group
Primary purpose
Other
Arms
experimental: The Donor App
Interventions
The Donor App
Primary outcome measure
Central contacts
Locations
The Johns Hopkins Hospital
Recruiting
Baltimore, Maryland, United States, 21218
Contacts
Principal Investigator:
Andrew Cameron, MD PhD
Sponsor
Johns Hopkins University
Last update posted
Nov 10, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Johns Hopkins University on 2025-11-10.